Finance, Compliance and Operations
Investment and Operations Team
Jeff Crispen is the Chief Financial Officer of BioImpact Equities (f/k/a Burrage Capital).
Previously Jeff served as the Chief Operating Officer, Chief Financial Officer, and Chief Compliance Officer at Cambridge Square Capital, a Boston-based relative-value volatility arbitrage hedge fund he helped launch in 2016. Prior to that, he was the Chief Operating Officer and Chief Financial Officer for Feingold O’Keeffe Capital (later sold to NewStar Financial), a Boston-based multi-product alternative credit manager and previously the Chief Financial Officer for Boldwater Capital Management.
Jeff began his career as an auditor at Arthur Andersen, and later joined the Cayman Islands office of Ernst & Young. Jeff then joined Deloitte as a senior manager in their investment management practice.
Jeff earned his B.S. in Business Administration with a concentration in accounting with honors from the University of Connecticut.